AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06244966 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: HIV diagnostic testing
Description: Finger-prick capillary blood will be tested alongside venous blood
Study NCT06514612 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: STN1013800 (0.1% Oxymetazoline Hydrochloride) eye drops in single dose containers
Description: STN1013800 (0.1% Oxymetazoline Hydrochloride) eye drops in single dose containers
Study NCT06514612 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (0% Oxymetazoline Hydrochloride) eye drops in single dose containers
Description: Placebo (0% Oxymetazoline Hydrochloride) eye drops in single dose containers
Study NCT06510361 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epcoritamab
Description: Humanized IgG1 bispecific antibody, 5 or 60 mL vial, via subcutaneous (under the skin) injection per protocol.
Study NCT06523634 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiotherapy (SBRT)
Description: 5 fractions of SBRT to the prostate bed with or without whole pelvic radiotherapy Treatment every other day.
Study NCT06523634 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: SOC RT
Description: Standard salvage radiotherapy to the prostate bed with or without whole pelvic radiotherapy. Each participating centre can specify upfront which RT schedule will be used in the control arm, with the choice between the following schedules:~* Hypofractionated: 20 fractions (Daily treatment (OTT 4-5 weeks))~* Normofractionated: 32-35 fractions (Daily treatment (OTT 7-8 weeks))
Study NCT05354258 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albendazole
Description: Anthelminthic drugs for the treatment of soil-transmitted helminths
Study NCT05354258 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Praziquantel
Description: Anthelminthic drugs for the treatment of schistosomiasis
Study NCT05354258 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amodiaquine
Description: SMC partner drug
Study NCT05354258 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Amodiaquine
Description: SMC partner drug
Study NCT05354258 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sulfadoxine pyrimethamine
Description: SMC partner drug
Study NCT05354258 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sulfadoxine pyrimethamine
Description: SMC partner drug
Study NCT06301152 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high intensive laser
Description: high-intensity laser ,three times in a week, for three weeks, 9 session
Study NCT06301152 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: extracorporeal shock wave therapy
Description: extracorporeal shock wave therapy, once a week, for three weeks ,3 times,
Study NCT06277726 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Emotional freedom technique group
Description: Emotional freedom technique will be applied to women in this group before intrauterine device application.
Study NCT06277726 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music group
Description: Women in this group will wear headphones and listen to music throughout the intrauterine device application.
Study NCT06277726 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control group
Description: No intervention will be applied to women in the control group.
Study NCT04914351 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HY-0102
Description: Multiple dose cohorts, 60 minute IV infusion, every two weeks, 28 days as a cycle
Study NCT06603103 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: SPHERIKA prosthesis
Description: total knee arthroplasty with kinematic alignement with SPHERIKA prosthesis
Study NCT06603103 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ORIGIN prosthesis
Description: total knee arthroplasty with kinematic alignement with ORIGIN prosthesis
Study NCT05817357 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rensair Compact air purifier unit
Description: Installation of Rensair Compact air purifier (Rensair Ltd.) in the homes of children/young people participating in this study
Study NCT05095337 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]SHR1459
Description: Patients will receive single dose of orally \[14C\]SHR1459 on Day 1.
Study NCT06617468 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: computer-aided diagnosis with explainable AI
Description: Perform a same test to estimate the pathologic diagnosis on 200 NBI still images with computer-aided diagnosis with explainable AI.
Study NCT05372900 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Test Product
Description: Whey Protein Isolate with Mulberry leaf extract
Study NCT05372900 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Product
Description: Wheat Protein Hydrolysate
Study NCT04726488 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Periareolar Approach in Minimally Invasive Cardiac Surgery (PAMI Technique)
Description: To study the feasibility and safety of periareolar minimally invasive surgery protocol in patients undergoing periareolar minimally invasive surgery vs. Control group (inframammary approach).
Study NCT04726488 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: inframammary approach
Description: To study the feasibility and safety of periareolar minimally invasive surgery protocol in patients undergoing periareolar minimally invasive surgery vs. Control group (inframammary approach).
Study NCT04755725 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Epidural catheter
Description: epidural catheter inserted pre induction
Study NCT04755725 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: rectus sheath catheter
Description: The surgeon will place one hand inside the abdomen and with the other hand inserted the Tuohy needle through the skin and fascia. The surgeon will feel when the needle tip is just superfacial to interface between the peritoneum and muscle layer and avoid penetration of inferior epigastric artery. The procedure will be repeated on the contralateral
Study NCT06617468 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: computer-aided diagnosis with deep learning
Description: Perform a same test to estimate the pathologic diagnosis on 200 NBI still images with computer-aided diagnosis with deep Iearning.
Study NCT06407505 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupressure group
Description: LI4 acupressure applied group.
Study NCT06407505 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo group
Description: Group where acupressure was applied to an area 1.5 cm away at the LI4 acupressure point
Study NCT05453422 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-Acupressure
Description: Acupressure is a therapy method performed with an instrument or hand, fingertip, palm, elbow, knee, thumb relaxation and wrist bands on various points representing the waist organs in order to ensure the continuation and balance of the energy in our body.
Study NCT04367766 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Prosthetically driven implant placement
Description: Insertion of an osseointegrated implant into the bone of anterior maxilla/mandible, following the right prosthetic plan
Study NCT05421377 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: clinical assessment
Description: screening of patients at risk for developing unilateral or bilateral lower limb lymphedema
Study NCT05053399 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Model Series ZXT
Description: Investigational intraocular lens replaces the natural lens removed during cataract surgery in both eyes.
Study NCT04505085 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Dads Healthy Families: Outdoor Education
Description: The intervention will include outdoor education and physical activity opportunities at various outdoor parks. The program will be held one day a week for eight consecutive weeks. Parks and Recreation will facilitate and run the program. Each session will last 60 minutes and include a brief educational discussion and opportunities for various games and activities. Each session will have a special theme relevant to the outdoors. Families will also receive a home toolbox to facilitate activity and learning outside of the program. Feedback on physical activity will be provided at the beginning and the end of the program.
Study NCT04505085 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Dads Healthy Families: Fitness
Description: The intervention will include physical activity opportunities at a community center. The program will be held one day a week for eight consecutive weeks. Parks and Recreation will facilitate and run the program. Each session will last 60 minutes and include a brief educational discussion and opportunities for various games and activities. Families will also receive a home toolbox to facilitate activity outside of the program. Feedback on physical activity will be provided at the beginning and the end of the program.
Study NCT05571462 — intervention group
Intervention type: OTHER
Intervention: Activity monitor group
Description: No intervention will be applied. All included patients will be monitored with body-worn physical activity monitors during two periods.
Study NCT06491420 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: fixation with arthroscopy
Description: the pipkin fracture is fixed with the help of arthroscopy and percutaneous methods.
Study NCT06739538 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Bobath exercises
Description: Bobath concept, are therapeutic techniques designed to improve motor control and function in individuals with neurological conditions, particularly those with cerebral palsy. These exercises focus on facilitating normal movement patterns, enhancing postural stability, and reducing muscle spasticity. The approach emphasizes individualized treatment, utilizing hands-on techniques to promote movement awareness and encourage the development of functional skills. By reinforcing weak movements and inhibiting overactive ones, Bobath exercises aim to enhance overall motor abilities and improve the quality of life for affected individuals.
Study NCT06739538 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Gasotransmitters
Description: such as nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H₂S), are small gaseous signaling molecules that play key roles in various physiological functions, including the regulation of muscle tone and neuroinflammation. In the context of spastic diplegic cerebral palsy (CP), gasotransmitters may help reduce spasticity and pain. Gasotransmitters help reduce spasticity and pain in children with spastic diplegic cerebral palsy through multiple mechanisms: Muscle relaxation and improved blood flow reduce muscle tightness, Anti-inflammatory and neuroprotective properties help minimize the damage that exacerbates spasticity.They also modulate pain pathways, both centrally and peripherally, reducing pain perception.
Study NCT06737146 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT027 cells suspension
Description: MT027: CRISPR/Cas9 edited B7H3-specific allogeneic CAR-T cells
Study NCT06739512 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Extensive Electro-Anatomical Guided Ablation
Description: Ablation using PFA. Combination of anatomical and electrogram-guided ablation techniques.
Study NCT06739512 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Anatomical Guided Ablation
Description: Ablation using PFA. Guided by anatomical landmarks without potential mapping
Study NCT05170191 — intervention group
Intervention type: BEHAVIORAL
Intervention: Sleep Deprivation
Description: The participants will stay awake for 24 hours.
Study NCT05394545 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nu-V3
Description: The Nu-V3 device provides a continuous flow of intermittent, low frequency electrical pulses to the ear's specific cranial nerve endings. This treatment is delivered 24 hours a day for the first 12 weeks, then is delivered two weeks on, one week off for the following 12 weeks.
Study NCT05417828 — intervention group
Intervention type: DEVICE
Intervention: Emulation of Active Daily Living tasks with a robotic device (SPINDLE)
Description: SPINDLE will provide an assistive and resistive force to aid in rehabilitating the subject's upper limb
Study NCT06333756 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cross education
Description: Cross education training of the biceps brachii (12 rep./set, 3sets, 60%MVIC,180°/s, eccentric contraction)
Study NCT05117632 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ALTO-100 PO tablet
Description: one tablet twice daily
Study NCT04881656 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Help is in Your Hands
Description: HIIYH is a set of 16 online educational modules for caregivers of children with social-communication delays or elevated likelihood of ASD.
Study NCT06419309 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Description: Four different dietary interventions are planned.~* Gluten-free, lactose-free diet,~* Diet enriched with Aronia Melanocarpa,~* Gluten-free, lactose-free and enriched with Aronia Melanocarpa diet,~* Healthy diet
Study NCT06481540 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Expiratory muscle strength training + SpiroGym application
Description: Participants will performe an intensive home-based expiratory muscle training programme using an Expiratory Muscle Trainer (EMST150; Aspire Products, LLC, United States), which provide a pressure- threshold range from 30 to 150 cmH20. EMST therapy sessions will be completed at home on 5 days of the patients choosing per week. Participants will be instructed to perform five sets of five forceful expirations coupled with SpiroGym app. per training session for 8 weeks (intensive training period). After this period, participants will perform an additional 16 weeks of maintenance EMST. EMST therapy sessions will be completed at home on two days (minimum) of the participant's choosing each week.
Study NCT06481540 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Expiratory muscle strength training
Description: Participants will performe an intensive home-based expiratory muscle training programme using an Expiratory Muscle Trainer (EMST150; Aspire Products, LLC, United States), which provide a pressure- threshold range from 30 to 150 cmH20. EMST therapy sessions will be completed at home on 5 days of the patients choosing per week. Participants will be instructed to perform five sets of five forceful expirations per training session for 8 weeks (intensive training period).After this period, participants will perform an additional 16 weeks of maintenance EMST. EMST therapy sessions will be completed at home on two days (minimum) of the participant's choosing each week.
Study NCT06218524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Haloperidol Tablets
Description: Haloperidol tablet 6mg, Oral, Triple/Day
Study NCT06218524 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Temozolomide, 150mg/kg, Oral, Once/Day, 5/28 days
Study NCT05154929 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dietary and physical activity JITAI delivered through the myBPmyLife app
Description: A Fitbit smartwatch and home blood pressure monitor will be mailed to participants (in both the experimental and control arms). Participants in the intervention arm then will set up and utilize the myBPmyLife app. This app includes push notifications to promote increased physical activity and improve low-sodium food choices, establish goal setting for weekly step count and low sodium food choices, and deliver feedback on achieving the goals using a dashboard visualization within the mobile application.
Study NCT05154929 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Group
Description: Participants will receive the myBPmyLife app, a smartwatch, and blood pressure cuff. The myBPmyLife app will not be fully activated (as they are in the control arm). They will be provided with the option of downloading and installing a mHealth app that is publicly available. In this arm they will also perform the blood pressure monitoring, but do not receive the intervention components through the myBPmyLife app.
Study NCT06397066 — intervention group
Intervention type: PROCEDURE
Intervention: White light endoscopy group
Description: White light endoscopy observe the characteristics of mucosa under white light
Study NCT06397066 — intervention group
Intervention type: PROCEDURE
Intervention: Magnifying endoscopy group
Description: NBI+ME to observe the non atrophic area of the gastric fundus gland. The results depend on the ratio of gastric fundus gland.
Study NCT06739512 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Electrogram Guided Ablation
Description: Ablation using PFA. Guided by real-time electrogram characteristics from a multi-electrode catheter.
Study NCT06094829 — intervention group
Intervention type: OTHER
Intervention: Oral cytobrush
Description: Oral epithelial cells will be collected during routine odontology appointments, upon documented non-opposition, via minimally invasive cytobrush sampling of the inner cheek
Study NCT05644730 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Fusion closed loop glucose control system
Description: The FUSION system will be used to control the subjects glucose to a range of 100-140 mg/dL. Data will be collected for up to 24 hours, or upon early termination of the study session.
Study NCT06377995 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo technique
Description: The patient is in a supine position with a 90° knees flexion. The osteopath lies cephalad to the patient and places their hands on their shoulders.
Study NCT05242744 — intervention group
Intervention type: DRUG
Intervention: [18F]FluorThanatrace
Description: Investigational radiopharmaceutical used with Positron Emission Tomography (PET/CT) imaging that may provide a non-invasive measurement of PARP-1 expression
Study NCT06377995 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diaphragm protocol
Description: The patient is in a supine position with a 90° knees flexion.To stretch the diaphragm, the osteopath stands at the head of the bed and places his hands on the lower edge of the ribcage and accompanies the lifting of the ribs during inhalation and maintains it during deep exhalation for up to 2 sets of 10 deep breaths separated by 1 minute. For the neuromuscular technique, the osteopath is positioned contralateral to the side to be treated and slides with the thumb under the lower part of the thorax, applying a force in the opposite direction.To inhibit the phrenic centre, the osteopath places one hand on the sternum in a caudal direction and the other in the projection of the phrenic centre in a cephalic direction.The participant inhales deeply and the osteopath presses in both directions during the expiratory phase for 10 respiratory cycles.
Study NCT06227923 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PRO-HOME intervention
Description: Patients are transferred to the apartment inside the hospital setting and are evaluated and assessed also using technological devices
Study NCT04478422 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle strengthening with vascular occlusion
Description: The muscle strengthening group with partial vascular occlusion will perform the strengthening exercises: single leg squat on 25 ° inclined plane, eccentric + isometric + concentric quadriceps exercise and deep squat. The equipment for vascular occlusion will be positioned over the proximal portion of the lower limb to be treated, just below the gluteal fold and inguinal ligament (Tennent et al. 2017). The pressure must be maintained during all series of exercises (approximately 5 minutes) (Bryk et al. 2016; Ferraz et al. 2018; Giles et al. 2017). If necessary, the pressure can be adjusted at intervals and after the end of the exercise, an interval of 5 minutes is suggested for blood reperfusion.
Study NCT04478422 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional muscle strengthening
Description: The conventional muscle strengthening group perform the same exercises as the intervention group: One-legged squat on a 25 ° inclined plane, eccentric + isometric + concentric quadriceps exercise and deep squat, however, without restriction on blood flow.
Study NCT04765462 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogeneic γδ T cells
Description: Phase 1:Enrolled patents will be administered allogeneic γδ T cells from 2x10\^6/kg, 1 x10\^7/kg to 5x10\^7/kg every 2-4 weeks to determine the recommended dose level.~Phase 2: Enrolled patents will be administered allogeneic γδ T cells at the recommended dose level to confirm the efficacy.~Whether or not in combination with other therapies will be determined by research physicians according to the disease status of enrolled patients.
Study NCT05537181 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BTL-899; HPM-6000UF Treatments
Description: The two devices will be used separately in two different treatments. However one treatment visit can comprise both treatments. The BTL-899 will be applied over the abdomen, and the device will induce visible muscle contractions along with mild heating of the muscles. Four (4) treatments once a week will be delivered. The HPM-6000UF device will induce pelvic floor muscle contractions. Six (6) treatments 2-4 days apart will be delivered.
Study NCT06218524 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Temozolomide
Description: Temozolomide, 150mg/kg, Oral, Once/Day, 5/28 days